Polymorphisms of the Interferon gamma gene and coronary artery disease in the Korean population

Molecular Biology Reports

Volumn 39, Issue 5, 2012, Pages 5425-5432

  Kim, Hak Jae ^a   Kang, Sung Wook ^b   Chung, Joo Ho ^b   Kim, Soo Joong ^b   Choe, Bong Keun ^b  

^a Soonchunhyang University   (South Korea)

^b Kyung Hee University Hospital   (South Korea)

Author keywords

Coronary artery disease; Interferon gamma (IFNG); Microsatellite; Single nucleotide polymorphism; Vessel stenosis

Indexed keywords

GAMMA INTERFERON; MICROSATELLITE DNA; IFNG PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE SEVERITY; ETHNIC GROUP; FEMALE; GENE; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC MARKER; GENETIC PREDISPOSITION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HUMAN; INTERFERON GAMMA GENE; INTRON; KOREAN; MAJOR CLINICAL STUDY; MALE; POPULATION GENETICS; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; DEMOGRAPHY; GENE FREQUENCY; GENETICS; MIDDLE AGED; NUCLEOTIDE REPEAT; SOUTH KOREA;

AGED; CORONARY ARTERY DISEASE; DEMOGRAPHY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENETICS, POPULATION; HUMANS; INTERFERON-GAMMA; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; REPETITIVE SEQUENCES, NUCLEIC ACID; REPUBLIC OF KOREA;

EID: 84862655712     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-011-1342-9     Document Type: Article

References (36)

1. Lane DA, Grant PJ (2000) Role of hemostatic gene polymorphisms in venous and arterial thrombotic disease. Blood 95(5):1517-1532
2. Lindahl B, Toss H, Siegbahn A, Venge P, Wallentin L (2001) Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease FRISC Study Group. Fragmin during instability in coronary artery disease. N Eng J Med 343(16):1139-1147
3. Frangogiannis NG, Smith CW, Entman ML (2002) The inflammatory response in myocardial infarction. Cardiovasc Res 53(1):31-47
4. Hanson G (2005) Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 352(16):1685-1695
5. Libby P (2002) Inflammation in atherosclerosis. Nature 420(6917):868-874
6. Shah PK (2007) Molecular mechanisms of plaque instability. Curr Opin Lipidol 18(5):492-499
7. Mori T, Sasaki J, Kawaguchi H, Handa K, Takada Y, Matsunaga A, Kono S, Arakawa K (1995) Serum glycoproteins and severity of coronary atherosclerosis. Am Heart J 129(2):234-238
8. Ikonomidis I, Andreotti F, Economou E, Stefanadis C, Toutouzas P, Nihoyannopoulos P (1999) Increased proinflammatory cytokines in patients with chronic stable angina and their reduction by aspirin. Circulation 100(8):793-798
9. Woods A, Brull DJ, Humphries SE, Montgomery HE (2000) Genetics of inflammation and risk of coronary artery disease: the central role of interleukin-6. Eur Heart J 21(19):1574-1583
10. Pasqui AL, Di Renzo M, Bova G, Maffei S, Pompella G, Auteri A, Puccetti L (2006) Pro-inflammatory/anti-inflammatory cytokine imbalance in acute coronary syndromes. Clin Exp Med 6(1):38-44
11. Hutchinson JV, Pravica V, Sinnot PJ (1998) Genetic regulation of cytokine synthesis: consequences for acute and chronic organ allograft rejection. Graft 1:15-21
12. Bidwell J, Keen L, Gallacher G, Kimberly R, Huizinga T, McDermott MF, Oksenberg J, McNicholl J, Pociot F, Hardt C, D'Alfonso S (1999) Cytokine gene polymorphism in human disease: online databases. Genes Immunity 1(1):3-19
13. Topol EJ, Smith J, Plow EF, Wang QK (2006) Genetic susceptibility to myocardial infarction and coronary artery disease. Hum Mol Genet 15:117-123
14. Olivieri F, Antonicelli R, Cardelli M, Marchegiani F, Cavallone L, Mocchegiani E, Franceschi C (2006) Genetic polymorphisms of inflammatory cytokines and myocardial infarction in the elderly. Mech Ageing Dev 127(6):552-559
15. Arroyo-Espliguero R, Avanzas P, Jeffery S, Kaski JC (2004) CD14 and toll-like receptor 4: a link between infection and acute coronary events? Heart 90(9):983-988
16. Kiechl S, Lorenz E, Reindl M, Wiedermann CJ, Oberhollenzer F, Bonora E, Willeit J, Schwartz DA (2002) Toll-like receptor 4 polymorphisms and atherogenesis. N Engl J Med 347(3): 185-1192
17. Ameziane N, Beillat T, Verpillat P, Chollet-Martin S, Aumont MC, Seknadji P, Lamotte M, Lebret D, Ollivier V, de Prost D (2003) Association of the toll-like receptor 4 gene Asp299Gly polymorphism with acute coronary events. Arterioscler Thromb Vasc Biol 23(12):e61-e64
18. Edfeldt K, Bennet AM, Eriksson P, Frostegård J, Wiman B, Hamsten A, Hansson GK, de Faire U, Yan ZQ (2004) Association of hyporesponsive toll-like receptor 4 variants with risk of myocardial infarction. Eur Heart J 25(16):1447-1453
19. Dwyer JH, Allayee H, Dwyer KM, Fan J, Wu H, Mar R, Lusis AJ, Mehrabian M (2004) Arachidonate 5-lipoxygenase promoter genotype, dietary arachidonic acid, and atherosclerosis. N Engl J Med 350(1):29-37
20. Helgadottir A, Manolescu A, Helgason A, Thorleifsson G, Thorsteinsdottir U, Gudbjartsson DF, Gretarsdottir S, Magnusson KP, Gudmundsson G, Hicks A, Jonsson T, Grant SF, Sainz J, O'Brien SJ, Sveinbjornsdottir S, Valdimarsson EM, Matthiasson SE, Levey AI, Abramson JL, Reilly MP, Vaccarino V, Wolfe ML, Gudnason V, Quyyumi AA, Topol EJ, Rader DJ, Thorgeirsson G, Gulcher JR, Hakonarson H, Kong A, Stefansson K (2006) A variant of the gene encoding leukotriene A4 hydrolase confers ethnicity-specific risk of myocardial infarction. Nat Genet 38(1):68-74
21. Swanberg M, Lidman O, Padyokov L, Eriksson P, Akesson E, Jagodic M, Lobell A, Khademi M, Börjesson O, Lindgren CM, Lundman P, Brookes AJ, Kere J, Luthman H, Alfredsson L, Hillert J, Klareskog L, Hamsten A, Piehl F, Olsson T (2005) MHC2TA is associated with differential MHC molecule expression and susceptibility to multiple sclerosis, rheumatoid arthritis and myocardial infarction. Nat Genet 37(5):486-494
22. Pravica V, Perrey C, Stevens A, Lee JH, Hutchinson IV (2000) A single nucleotide polymorphism in the first intron of the human IFN-α gene: absolute correlation with a polymorphic CA microsatellite marker of high IFN-α gene. Hum Immunol 61(9):863-866
23. Khani-Hanjani A, Lacaille D, Hoar D, Chalmers A, Horsman D, Anderson M, Balshaw R, Keown PA (2000) Association between dinucleotide repeat in non-coding region of interferon-gamma gene and susceptibility to, and severity of, rheumatoid arthritis. Lancet 356(9232):820-825
24. Jahromi M, Millward A, Demaine A (2000) A CA repeat polymorphism of the IFN-gamma gene is associated with susceptibility to type 1 diabetes. J Interferon Cytokine Res 20(2):187-190
25. Dufour C, Capasso M, Svahn J, Marrone A, Haupt R, Bacigalupo A, Giordani L, Longoni D, Pillon M, Pistorio A, Di Michele P, Iori AP, Pongiglione C, Lanciotti M, Iolascon A, Associazione Italiana di Emato-Oncologia Pediatrica (AIEOP); Department of Hematology, Ospedale S. Martino, Genoa, Italy (2004) Homozygosis for (12) CA repeats in the first intron of the human IFNgamma gene is significantly associated with the risk of aplastic anaemia in Caucasian population. Br J Haematol 126(5):682-685
26. Lee JY, Goldman D, Piliero LM, Petri M, Sullivan KE (2001) Interferon-gamma polymorphisms in systemic lupus erythematosus. Genes Immun 2(5):254-257
27. Bream JH, Carrington M, O'Toole S, Dean M, Gerrard B, Shin HD, Kosack D, Modi W, Young HA, Smith MW (2000) Polymorphisms of the human IFNG gene noncoding regions. Immunogenetics 51(1):50-58
28. Daher S, Shulzhenko N, Morgun A, Mattar R, Rampim GF, Camano L, DeLima MG (2003) Associations between cytokine gene polymorphisms and recurrent pregnancy loss. J Reprod Immunol 58(1):69-77
29. Dabora SL, Roberts P, Nieto A, Perez R, Jozwiak S, Franz D, Bissler J, Thiele EA, Sims K, Kwiatkowski DJ (2002) Association between a high-expressing interferon-gamma allele and a lower frequency of kidney angiomyolipomas in TSC2 patients. Am J Hum Genet 71(4):750-758
30. Pravica V, Asderakis A, Perrey C, Hajeer A, Sinnott PJ, Hutchinson IV (1999) In vitro production of IFN-c correlates with CA repeat polymorphism in the human IFN-c gene. Eur J Immunogenet 26(1):1-3
31. Awata T, Matsumoto C, Urakami T, Hagura R, Amemiya S, Kanazawa Y (1994) Association of polymorphism in the interferon gamma gene with IDDM. Diabetologia 37(11):1159-1162
32. Pociot F, Veijola R, Johannesen J, Hansen PM, Lorenzen T, Karlsen AE, Reijonen H, Knip M, Nerup J (1997) Analysis of an interferon-gamma gene (IFNG) polymorphism in Danish and Finnish insulin-dependent diabetes mellitus (IDDM) patients and control subjects. Danish Study Group of Diabetes in Childhood. J Interferon Cytokine Res 17(2):87-93
33. Abbott W, Gane E, Winship I, Munn S, Tukuitonga C (2007) Polymorphism in intron 1 of the interferon-gamma gene influences both serum immunoglobulin E levels and the risk for chronic hepatitis B virus infection in Polynesians. Immunogenetics 59(3):187-195
34. Bouzgarrou N, Hassen E, Farhat K, Bahri O, Gabbouj S, Maamouri N, Ben Mami N, Saffar H, Trabelsi A, Triki H, Chouchane L (2009) Combined analysis of interferon-gamma and interleukin-10 gene polymorphisms and chronic hepatitis C severity. Hum Immunol 70(4):230-236
35. Omrani MD, Bushehri B, Bagheri M, Salari-Lak S, Alipour A, Anoshae MR, Massomi R (2009) Role of IL-10-1082, IFNgamma ?874, and TNF-alpha-308 genes polymorphisms in suicidal behavior. Arch Suicide Res 13(4):330-339
36. Manginas A, Tsiavou A, Chaidaroglou A, Giamouzis G, Degiannis D, Panagiotakos D, Cokkinos DV (2008) Inflammatory cytokine gene variants in coronary artery disease patients in Greece. Coron Artery Dis 19(8):575-582